Walleye Trading’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
6,400
-4,800
-43% -$995K ﹤0.01% 2145
2026
Q1
$2.51M Sell
11,200
-900
-7% -$224K ﹤0.01% 1569
2025
Q4
$2.91M Buy
12,100
+5,400
+81% +$1.38M ﹤0.01% 1652
2025
Q3
$1.83M Sell
6,700
-7,500
-53% -$2.05M ﹤0.01% 1872
2025
Q2
$3.66M Buy
14,200
+5,400
+61% +$1.29M 0.01% 1376
2025
Q1
$1.97M Buy
8,800
+2,100
+31% +$490K ﹤0.01% 1643
2024
Q4
$1.53M Sell
6,700
-5,400
-45% -$1.3M ﹤0.01% 1862
2024
Q3
$2.95M Buy
12,100
+4,900
+68% +$1.09M 0.01% 1446
2024
Q2
$1.38M Buy
7,200
+2,100
+41% +$426K ﹤0.01% 1844
2024
Q1
$1.01M Sell
5,100
-7,700
-60% -$1.41M ﹤0.01% 2240
2023
Q4
$2.2M Buy
12,800
+10,600
+482% +$1.63M ﹤0.01% 1852
2023
Q3
$325K Buy
2,200
+2,100
+2,100% +$380K ﹤0.01% 3308
2023
Q2
$21.9K Sell
100
-200
-67% -$44.6K ﹤0.01% 4122
2023
Q1
$65.7K Buy
+300
New +$65.1K ﹤0.01% 4003
2022
Q4
– Sell
-6,400
Closed -$1.4M – 5343
2022
Q3
$1.4M Buy
6,400
+2,900
+83% +$660K ﹤0.01% 1985
2022
Q2
$734K Buy
+3,500
New +$745K ﹤0.01% 2520
2022
Q1
– Sell
-2,200
Closed -$573K – 5838
2021
Q4
$573K Buy
2,200
+500
+29% +$130K ﹤0.01% 2814
2021
Q3
$448K Sell
1,700
-3,100
-65% -$848K ﹤0.01% 3023
2021
Q2
$1.18M Sell
4,800
-4,900
-51% -$1.03M ﹤0.01% 1963
2021
Q1
$1.88M Buy
9,700
+6,900
+246% +$1.38M 0.01% 1380
2020
Q4
$595K Buy
2,800
+2,000
+250% +$399K ﹤0.01% 2500
2020
Q3
$137K Sell
800
-12,500
-94% -$2.31M ﹤0.01% 3229
2020
Q2
$2.55M Buy
13,300
+7,600
+133% +$1.24M 0.02% 922
2020
Q1
$840K Sell
5,700
-4,700
-45% -$749K 0.01% 1436
2019
Q4
$1.61M Buy
10,400
+2,700
+35% +$389K 0.01% 1382
2019
Q3
$1.04M Buy
7,700
+2,800
+57% +$367K 0.01% 1569
2019
Q2
$598K Sell
4,900
-1,700
-26% -$188K 0.01% 2050
2019
Q1
$686K Buy
6,600
+3,800
+136% +$392K 0.01% 1982
2018
Q4
$319K Buy
2,800
+2,400
+600% +$257K ﹤0.01% 2920
2018
Q3
$46K Sell
400
-800
-67% -$87.6K ﹤0.01% 4585
2018
Q2
$124K Buy
+1,200
New +$121K ﹤0.01% 3947
2018
Q1
– Sell
-200
Closed -$17K – 4739
2017
Q4
$17K Sell
200
-300
-60% -$24.8K ﹤0.01% 4189
2017
Q3
$38K Sell
500
-300
-38% -$22.9K ﹤0.01% 3844
2017
Q2
$63K Buy
800
+500
+167% +$35.8K ﹤0.01% 3783
2017
Q1
$21K Sell
300
-700
-70% -$48.4K ﹤0.01% 4123
2016
Q4
$62K Sell
1,000
-1,700
-63% -$104K ﹤0.01% 3526
2016
Q3
$175K Sell
2,700
-5,100
-65% -$339K ﹤0.01% 2908
2016
Q2
$493K Buy
7,800
+3,900
+100% +$230K ﹤0.01% 2225
2016
Q1
$226K Sell
3,900
-700
-15% -$39.6K ﹤0.01% 2683
2015
Q4
$247K Buy
4,600
+3,600
+360% +$203K ﹤0.01% 2510
2015
Q3
$51K Hold
1,000
– – ﹤0.01% 3488
2015
Q2
$56K Sell
1,000
-100
-9% -$6.31K ﹤0.01% 3416
2015
Q1
$79K Buy
1,100
+800
+267% +$52K ﹤0.01% 2817
2014
Q4
$17K Hold
300
– – ﹤0.01% 3757
2014
Q3
$15K Sell
300
-1,800
-86% -$91.7K ﹤0.01% 3679
2014
Q2
$107K Buy
+2,100
New +$104K ﹤0.01% 2436
2014
Q1
– Sell
-100
Closed -$5K – 3859
2013
Q4
$5K Sell
100
-200
-67% -$10.1K ﹤0.01% 3451
2013
Q3
$16K Sell
300
-300
-50% -$14.6K ﹤0.01% 2585
2013
Q2
$28K Buy
+600
New +$28.5K ﹤0.01% 2424

Other funds holding RMD

Walleye Trading's RMD Position: Q2 2026 in Review

Walleye Trading sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,335 shares — an estimated $277K sold.

Walleye Trading first reported a position in RMD in Q2 2013 and held it in 29 quarters. The position peaked at $2.95M in Q1 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Walleye Trading reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 1,335 ResMed shares in Q2 2026, an estimated $277K.
  • Walleye Trading first reported a position in ResMed in Q2 2013 and held it in 29 quarters.
  • Walleye Trading's ResMed position peaked at $2.95M in Q1 2024.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.